The Binding Site
Rubella MAb R22T is a new, purified monoclonal antibody to be used for the analysis and testing of the rubella virus. This novel monoclonal antibody has been designed for use as an integral component within enzyme immunoassay test procedures and is certain to benefit the needs of clinical, biopharmaceutical, and life science researchers, as well as manufacturers of in vitro diagnostic test kits. The antibody is sourced from mice and manufactured to a purity level of >95% while displaying exceptional sensitivity and specificity. In addition, the antibody offers excellent lot-to-lot consistencies and features an outstanding shelf-life of four years from the date of manufacture. It is supplied preservative-free and comes packaged in ergonomically designed 1.0 mg filled vials, with larger, bulk packaging configurations also available.
